Aclaris Therapeutics
ACRS
ACRS
99 hedge funds and large institutions have $289M invested in Aclaris Therapeutics in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 11 closing their positions.
Holders
99
Holders Change
+13
Holders Change %
+15.12%
% of All Funds
2.21%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
24
Increased
43
Reduced
20
Closed
11
Calls
$123K
Puts
$7K
Net Calls
+$116K
Net Calls Change
+$116K
Top Buyers
1 |
DM
1
Deerfield Management
New York
|
$43.6M |
2 |
BC
2
Broadfin Capital
New York
|
$13.9M |
3 |
MP
3
MFN Partners
Boston,
Massachusetts
|
$11.1M |
4 |
4
UBS Group
Zurich,
Switzerland
|
$9.73M |
5 |
5
BlackRock
New York
|
$26.8M |